# OnCo record atomic (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/atomic/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "atomic", "NCT02912559" ;
  schema:name "ATOMIC (Alliance A021502)"@en ;
  schema:description "Adding a year of immunotherapy to chemotherapy after surgery halved recurrences in stage III colon cancers with a broken DNA spell-checker."@en ;
  schema:url <https://onco.cc/trials/atomic/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02912559>, <https://ascopubs.org/doi/10.1200/JCO.2025.43.17_suppl.LBA1> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2017-10-16" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/msi-high-colorectal/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/folfox/> ;
  onco:companies <https://onco.cc/companies/alliance-oncology/> ;
  onco:terms <https://onco.cc/terms/msi/>, <https://onco.cc/terms/neoadjuvant-adjuvant/> ;
  onco:trials <https://onco.cc/trials/n0147/>, <https://onco.cc/trials/petacc-8/>, <https://onco.cc/trials/idea-collaboration/>, <https://onco.cc/trials/nct05855200/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-atomic-n-engl-j-med-2026/> .